Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this single center, randomized, open label study in relapsing Multiple
Sclerosis (MS) patients on PLEGRIDY (peginterferon beta-1a) is to assess the effect of
Preparation H (phenylephrine) Maximum Strength Cream compared to no topical treatment of
injection site erythema after PLEGRIDY injection.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health